REG - Imaging Biometrics - Grant of Share Options

Imaging BiometricsAnnouncement

07/08/2025 11:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250807:nRSG4317Ua&default-theme=true

RNS Number : 4317U  Imaging Biometrics Limited  07 August 2025

 

Imaging Biometrics Limited

("IB" or the "Company")

 

Grant of Share Options

 

The Board of Directors of IB approved, at the February board meeting of the
Company, the issuance of incentive share option awards ("Options") to key
personnel as part of the Company's ongoing strategy to align performance
incentives with long-term value creation.

 

The following Options were granted to key non-Board IB staff and service
providers:

 

 Options Granted  Exercise Price  Vesting Schedule from the date of grant (February 2025)
 1,000,000        £0.0145         50% after 1 year and the balance after 2 years
 550,000          £0.0145         50% after 1 year; 25 % vests after 2 years; the balance vests after
                                  3 years
 Up to 6,000,000  £0.04           1 000 000 vests after 1 year; each remaining tranche of 1 000 000
                                  vests upon a qualifying sale of IB Nimble, but not before the first
                                  anniversary of the grant

 

 

All Options held by IB staff are subject to continued employment at the time
of vesting.

 

The Directors of the Company accept responsibility for the contents of this
announcement.

 

 

 

-ENDS-

 

For further information, please contact:

 

 IQ-AI Limited

 Trevor Brown/Brett Skelly/Dr Musella

 Tel: 020 7469 0930

 Peterhouse Capital Limited (Financial Adviser and Broker)

 Tel: 020 7220 9797

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRPRMMTMTTMBMA